Terumo Operating Income 2012-2024 | TRUMY

Terumo operating income for the twelve months ending December 31, 2024 was $0.736B, a 26.46% decline year-over-year.

  • Terumo annual operating income for 2025 was $1.041B, a 7.65% increase from 2024.
  • Terumo annual operating income for 2024 was $0.967B, a 11.33% increase from 2023.
  • Terumo annual operating income for 2023 was $0.868B, a 15.87% decline from 2022.

Terumo Operating Income 2012-2024 | TRUMY

  • Terumo annual operating income for 2025 was $1.041B, a 7.65% increase from 2024.
  • Terumo annual operating income for 2024 was $0.967B, a 11.33% increase from 2023.
  • Terumo annual operating income for 2023 was $0.868B, a 15.87% decline from 2022.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$220.2B
Boston Scientific (BSX)$157B
Stryker (SYK)$154B
EssilorLuxottica (ESLOY)$136.6B
Medtronic (MDT)$119.2B
Lonza Group Ag (LZAGY)$50.3B
Haleon (HLN)$44.4B
ResMed (RMD)$40.3B
GE HealthCare Technologies (GEHC)$35.5B
Agilent Technologies (A)$34.1B
Koninklijke Philips (PHG)$25.2B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$19.3B
Baxter (BAX)$15B
Smith & Nephew SNATS (SNN)$13.9B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.9B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.3B